No abstract

Objectives: Frozen shoulder (adhesive capsulitis) is a common musculoskeletal disease that appears with a number of symptoms such as pain and constrained active and passive motions of the shoulder. Frozen shoulder mainly affects middle-aged adults. Local corticosteroids injection, oral corticosteroid, Platelet-Rich Plasma (PRP), NSAIDs, and physiotherapy may alleviate the symptoms. The aim of this study is to compare the efficacies of corticosteroid injection and PRP in treating frozen shoulder. Methods: A quasi-experimental research was performed on patients with frozen shoulder; to this end, 32 male and 109 female patients were enlisted in the study. The patients were divided randomly into two groups: those receiving (a) PRP and (b) corticosteroid injection. Results: No significant relation was noticed between the two groups after 12 weeks according to a range of motions in flexion ([Formula: see text] = 0.300), abduction ([Formula: see text] = 0.133), external rotation ( [Formula: see text] = 0.100), and internal rotation ([Formula: see text] = 0.206). In addition, no significant difference between pain and function scores was detected ([Formula: see text] = 0.103, 0.100). Conclusion: Based on our investigation, both corticosteroid injection and PRP are effective in treating adhesive capsulitis, and there is no notable difference in the effectiveness of these two treatment modalities in patients with frozen shoulder.

Background: The novel coronavirus has spread rapidly worldwide, with exceptionally high mortality in the elderly. Patients with hip fracture have an average age of 80 years, with an estimated 2.8 comorbidities per patient. This study aims to assess the impact of the COVID-19 pandemic on hip fracture care services and the associated mortality rate. Methods: PubMed, Medline, and Google Scholar databases were searched for relevant studies linked to mortality in COVID-19 patients who have undergone hip surgeries using the keywords “COVID-19” OR “SARS-cov-2” OR “Coronavirus Infections”; AND “Surgery” OR “Hip” OR “Fracture” OR “Orthopedics.” We included all patients with hip fractures but excluded pathological fractures and other non-traumatic hip pathologies 30 studies for the final review were selected according to the inclusion and exclusion criteria. Results: 30 studies were included in the review. The overall mortality was 10.52%. There was a significant difference in the mortality rate between patients with positive and negative tests and between the operative patients who tested positive and the operative patients who tested negative. Conclusions: COVID-19-infected elderly patients with hip fractures have a higher mortality rate than non-COVID-19 infected cases. Further studies are warranted to examine the morbidity and mortality rates in COVID-19-positive patients with hip fractures and investigate how these outcomes can be improved.